Synthesized in the USA
Lab & COAs
Every batch is third-party tested before release. Find the batch number on your label. Every batch is tested for identity and purity by an independent third-party laboratory before release. Find the batch number on your label and download its certificate.
- 01Synthesized in San Diego, CA
- 02Tested by an independent lab
- 03COA published per batch
- Glutathione · 2,000 mg GLU2000VAS0826 · 99.2% PDF GLU2000VAS0826
- KPV · 10 mg KPV10VAS0826 · 99.2% PDF KPV10VAS0826
- MOTS-C · 40 mg MOT40VAS0826 · 99.2% PDF MOT40VAS0826
- GHK-Cu · 50 mg GHK50VAS0826 · 99.3% PDF GHK50VAS0826
- Selank/Semax · 15 mg / 15 mg SLSM1515N0726 · >99.3% PDF SLSM1515N0726
- Semax · 10 mg SEM10N0726 · >99.4% PDF SEM10N0726
- Selank · 10 mg SEL10N0726 · >99.2% PDF SEL10N0726
- Tesamorelin · 10 mg TES10VAS0626 · >99.1% PDF TES10VAS0626
- NAD+ · 500 mg NAD500VAS0626 · >99.2% PDF NAD500VAS0626
- Kisspeptin · 5 mg KIS5VAS0626 · >99.4% PDF KIS5VAS0626
- CJC-1295/Ipamorelin · 7.5 mg / 10 mg CI710VAS0626 · >99.5% PDF CI710VAS0626
- AOD-9604 · 10 mg AOD10VAS0626 · >99.3% PDF AOD10VAS0626
| Product | Form | Strength | Batch | Tested | Purity | COA |
|---|---|---|---|---|---|---|
| Glutathione | Vial | 2,000 mg | GLU2000VAS0826 | 27 Aug 2026 | 99.2% | PDF ↓ GLU2000VAS0826 |
| KPV | Vial | 10 mg | KPV10VAS0826 | 24 Aug 2026 | 99.2% | PDF ↓ KPV10VAS0826 |
| MOTS-C | Vial | 40 mg | MOT40VAS0826 | 10 Aug 2026 | 99.2% | PDF ↓ MOT40VAS0826 |
| GHK-Cu | Vial | 50 mg | GHK50VAS0826 | 10 Aug 2026 | 99.3% | PDF ↓ GHK50VAS0826 |
| Selank/Semax | Nasal | 15 mg / 15 mg | SLSM1515N0726 | 28 Jul 2026 | >99.3% | PDF ↓ SLSM1515N0726 |
| Semax | Nasal | 10 mg | SEM10N0726 | 28 Jul 2026 | >99.4% | PDF ↓ SEM10N0726 |
| Selank | Nasal | 10 mg | SEL10N0726 | 28 Jul 2026 | >99.2% | PDF ↓ SEL10N0726 |
| Tesamorelin | Vial | 10 mg | TES10VAS0626 | 07 Jul 2026 | >99.1% | PDF ↓ TES10VAS0626 |
| NAD+ | Vial | 500 mg | NAD500VAS0626 | 07 Jul 2026 | >99.2% | PDF ↓ NAD500VAS0626 |
| Kisspeptin | Vial | 5 mg | KIS5VAS0626 | 07 Jul 2026 | >99.4% | PDF ↓ KIS5VAS0626 |
| CJC-1295/Ipamorelin | Vial | 7.5 mg / 10 mg | CI710VAS0626 | 07 Jul 2026 | >99.5% | PDF ↓ CI710VAS0626 |
| AOD-9604 | Vial | 10 mg | AOD10VAS0626 | 07 Jul 2026 | >99.3% | PDF ↓ AOD10VAS0626 |